4 news items
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
LQDA
18 Jun 24
within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADRT
ADSK
AFMD
3 Jun 24
State Court regarding its ongoing ranitidine litigation.
The Scotts Miracle-Gro Company
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
LQDA
13 May 24
approval of YUTREPIA for both PAH and PH-ILD. In late March 2024, Judge Andrews set aside the injunction issued in the original Hatch-Waxman litigation
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
LQDA
1 Apr 24
removed the injunction issued in the Original Hatch Waxman LitigationOn March 29, Judge Bates denied United Therapeutics' motion
- Prev
- 1
- Next